Work

Payer Coverage Considerations for Alzheimer Disease Blood-Based Biomarker Tests

Year: 2024

Type: article

Abstract: This Viewpoint discusses proactively preparing to make informed payer coverage decisions to help address current disparities in Alzheimer disease diagnosis and treatment.

Source: JAMA

DOI: 10.1001/jama.2024.19084

Authors: Patricia A. Deverka, Grace A. Lin, Kathryn A. Phillips

Institutions: University of California, San Francisco, Philip R. Lee Institute for Health Policy Studies

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Georgia State University, National Human Genome Research Institute

Awards: G639268905, G8611469384

OpenAlex ID: W4402984063

FWCI: 1.072

Cites: 6

Cited by: 4

Related to: 10